Social Media Sidebar

Announcement

Please sign up, comment on articles and bring your friends!

Current poll

PlanetTech is asking:

What do you think about our new web site?

Love it, indeed
Really good solution
Same as old one
The old one was better
This is a new option

Quote of the day

When seen through the lens of technology, few resources are truly scarce; they’re mainly inaccessible. 

 

Peter Diamandis

An anti-inflammatory 'smart drug' that activates only in high-inflammation areas

RATE THIS! +47
Posted in Science on 25th Jul, 2015 11:42 PM by AlexMuller

Ben-Gurion University of the Negev (BGU) in Israel and University of Colorado researchers have developed a dynamic anti-inflammatory “smart” drug that can target specific sites in the body and could enhance the body’s natural ability to fight infection while reducing side effects.

 
This protein molecule, reported in the current issue of Journal of Immunology, has an exceptional property: when injected, it’s  non-active. But upon reaching a local site with excessive inflammation, it becomes activated. Most other anti-inflammatory agents have broad effects in the body.
 
“This development is important because inhibition of inflammation in a non-specific manner reduces the natural ability to fight infections and is a common side effect of anti-inflammatory biologic therapeutics,” says Dr. Peleg Rider of BGU’s Department of Clinical Biochemistry and Pharmacology.
 
Using such a non-specific agent means any patient who suffers from local inflammation could be exposed to opportunistic infections at distant sites, such as lungs, which could risk tuberculosis, for example. This is especially a concern for immunosuppressed patients, as well as older patients and patients undergoing chemotherapy as part of an anti-cancer treatment course.
 
“The beauty of this invention lies in the use of a known natural biological code,” Rider explains. “We mimicked a natural process that occurs during inflammation.”
 
Here’s how it works. The protein molecule (known as Chimeric IL-1Ra) is actually a chimera, combining two protein domains, both originating from the potent inflammatory IL-1 (interleukin family) protein (a group of 11 cytokines). (IL-1 normally plays a central role in regulating both immune and inflammatory responses to infections.)
 
The first part of this chimeric protein (IL-1beta) keeps a potent IL-1 natural infllammatory inhibitor (known as IL-1Ra) inactive. But when the IL-1Ra protein molecule encounters inflammatory enzymes, it springs into action, overriding IL-1beta, and is cleaved (split open), releasing powerful active molecules to reduce inflammation.
 
Rider, along with BGU’s Dr. Eli Lewis and Prof. Charles Dinarello of the University of Colorado, demonstrated their findings in a mouse model of local inflammation. They showed that leukocytes, which infiltrate inflammatory sites, indeed activate the chimeric protein, which in turn reduces local inflammation. The extent of activation of the protein correlated with the amount of inflammatory stimuli.
 
“Thus, a point that is highly relevant to clinical practice arises. Upon resolution of inflammation, the activation of the protein is also reduced and side effects are avoided,” Rider explains.

Tags: druginflammationcancerchemotherapymedicineresearch

Read original article » Back to category

Comments

Author: Guest
Posted: 2015-07-26
+1
This is very impressive! Making reagents and potential drugs that would be active only at desired spots in the body is a recognised goal and very important one. To see this work for combating inflammation is great hope... Reply


 

Recent headlines

  • Posted in Software on 2017-12-17 22:27:47
    Ethereum, Litecoin and Ripple added to Bloomberg.....read more
    Posted in Science on 2017-12-17 22:22:12
    Blue Origin flies booster and crew capsule..read more
    Posted in Medicine on 2017-12-17 22:19:29
    Anti-aging drugs only a few years away..read more
    Posted in Online on 2017-12-15 13:43:41
    The FCC votes to repeal the 2015 net neutrality rules..read more
    Posted in Science on 2017-12-15 13:34:37
    How Clinical Trials Are Making the Case for MDMA in.....read more
Posted in Business on 2013-10-10 01:33
China is working towards a manned lunar mission in about.....read more
Posted in Business on 2013-10-20 07:17
Spacex says China is their main competitor for commercial.....read more
Posted in Software on 2013-10-20 06:43
Pirate Bay Browser Clocks 1,000,000 Downloads..read more
Posted in Medicine on 2013-10-10 02:10
Google reportedly investing hundreds of millions into new.....read more
Posted in Medicine on 2013-10-14 03:13
Endothelial Cells Can Repair and Regenerate Organs,.....read more
Posted in Science on 01.01.2010
Spacex says China is their main competitor for commercial.....read more
Posted in Science on 01.01.2010
Staring at Your Phone Could Be Making You Short Sighted..read more
Posted in Science on 01.01.2010
Oculus Rift virtual reality headset coming to mobile, but.....read more
Posted in Science on 01.01.2010
China is working towards a manned lunar mission in about.....read more
Posted in Science on 01.01.2010
Delivering drugs via nanoparticles to target mitochondria..read more

Recent Blog Posts

  • Posted by AlexMuller
    Martian landscapes formed from sand 'levitating' on a little.....read more
    Posted by AlexMuller
    Scientists detect comets outside our solar system..read more
    Posted by AlexMuller
    Advanced artificial limbs mapped in the brain..read more
    Posted by AlexMuller
    Bacteria have a sense of touch..read more
    Posted by AlexMuller
    Recurrent brain cancer: New hope with phase 1 clinical trial.....read more

Login to your Account

Login to your PlanetTech Account here

Username:
Password:
Remember me
or

Create a New Account

You just need username and password

The following errors occured:
Username:
Email:
Password:
Verify password:
Remember me